Kamila Kolanska

59PUBLICATIONS
254CO-AUTHORS
VenereologyPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Jul 13, 2026
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI).

|Feb 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome.

David B Beck, Maël Heiblig, Sinisa Savic

|Feb 11, 2026
Salvage therapy with JAK inhibitors in refractory Takayasu arteritis: a multicentre experience.

Arsène Mekinian, Sarah Meneses, Lucie Biard

|Jan 16, 2026
Characteristics and prognostic significance of myelodysplasia-related features in VEXAS syndrome.

Lin-Pierre Zhao, Olivier Kosmider, Maël Heiblig

|Dec 09, 2025
Reply.

Dafne Capelusnik, Tali Eviatar, Corrado Campochiaro

|Nov 25, 2025
Establishing a consensus definition of VEXAS flare for clinical research.

Lachelle D Weeks, Danielle Hammond, Sinisa Savic

Pageof 10

Frequent Collaborators

10 joint publications

Sophie Georgin-Lavialle

9 joint publications

Benjamin Terrier

8 joint publications

Corrado Campochiaro

6 joint publications

Yann Nguyen